COMMUNIQUÉS West-GlobeNewswire

Le Bal Rouge de la Fondation du CUSM amasse 2,106,445 $ pour l’innovation en santé au CUSM
03/06/2025
MONTRÉAL, 03 juin 2025 (GLOBE NEWSWIRE) -- Le Bal Rouge, l’événement phare de la Fondation du CUSM, a réuni les leaders les plus passionnés du monde des affaires, de la philanthropie et de la santé pour célébrer une [...]
The MUHC Foundation’s Le Bal Rouge Gala raises $2,106,445 million for innovation in health care at the MUHC’s Glen site
03/06/2025
MONTREAL, June 03, 2025 (GLOBE NEWSWIRE) -- The MUHC Foundation’s signature gala, Le Bal Rouge , brought together Montreal’s most passionate changemakers in business, philanthropy and health care to celebrate a decade [...]
Chemomab Announces New Patent Awards for Its First-in-Class Agent Nebokitug that is Positioned to Potentially Become the First Approved Drug for Primary Sclerosing Cholangitis
03/06/2025
—New Patent s Covering Use of Nebokitug for the Treatment of Liver Diseases including Primary Sclerosing Cholangitis Issued in China and Russia Providing Coverage Up T o 2041 — —Further Ex pands Protections Provided by [...]
Alignment Healthcare Named to 2025 Fortune 1000 List Following Strong Revenue Growth
03/06/2025
ORANGE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) has been named to the 2025 Fortune 1000 list, marking its debut among the top U.S. public companies ranked by total revenue. [...]
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
03/06/2025
MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/2025
CHARLESTOWN, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today [...]
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
03/06/2025
PITTSBURGH, June 03, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc . (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Goldman Sachs 46 th Annual Global Healthcare Conference on [...]
Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York
03/06/2025
LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today [...]
Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
03/06/2025
REDWOOD CITY, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]
Philips launches intelligent 3D imaging in Europe to empower faster stroke care, helping physicians save time, brain, and lives
03/06/2025
Demonstrated at LINNC Paris 2025, the company’s latest release of SmartCT delivers fast, intelligent 3D imaging in the Angio suite — helping physicians act with greater speed and confidence during a range of critical [...]
IMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 Study
03/06/2025
Consistent OS Efficacy Benefit Across Multiple Treatment Subgroups Demonstrates IMNN-001’s Ability to Recruit a Powerful Anti-Cancer Immune Response Results, presented simultaneously in oral presentation at ASCO 2025 [...]
Communiqué de presse : ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps
03/06/2025
ASCO : de nouvelles données sur le Sarclisa appuient l’administration sous-cutanée avec un injecteur sur le corps De nouvelles données provenant de deux études cliniques ont démontré que le Sarclisa administré par voie [...]
Press Release: ASCO: new Sarclisa data support subcutaneous administration with on-body injector
03/06/2025
ASCO: new Sarclisa data support subcutaneous administration with on-body injector New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector [...]
Rose Hill Life Sciences Executes Exclusive License Agreement with Johns Hopkins University for Restoration of Motor Function Post-Neurological Injury Using Psychedelics
03/06/2025
BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Rose Hill Life Sciences , a global leader in the research and intellectual property of premium psilocybin products, has signed an agreement with Johns Hopkins University to [...]
QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency
03/06/2025
Recent publications highlight the efficacy of QHSLab's digital assessments in primary care, offering benefits for providers, patients, and practice revenue. WEST PALM BEACH, FL, June 03, 2025 (GLOBE NEWSWIRE) -- QHSLab [...]
Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise
03/06/2025
Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, [...]
Nanox to Participate in Sidoti Small Cap Conference
03/06/2025
Management to present on Wednesday, June 11 at 1:45 PM ET PETACH TIKVA, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“ Nanox ” or the “ Company ”), an innovative medical imaging [...]
NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary
03/06/2025
EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
03/06/2025
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) announced today the filing by Black Titan Corporation with the U.S. Securities and Exchange Commission (“ [...]

Pages